Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71205-335

5 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71205-335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Atorvastatin Structure)

Structure (Atorvastatin Structure)
Chemical structure of atorvastatin calcium, showing the molecular arrangement including the calcium ion and associated hydrate molecules.*
FDA Label Image

Figure-01 (Atorvastatin Figure 01)

Figure-01 (Atorvastatin Figure 01)
A line graph comparing cumulative incidence percentages over time in years for Atorvastatin versus placebo. The Atorvastatin line shows a lower cumulative incidence than placebo across 3.5 years, with hazard ratio (HR) and p-value noted on the graph.*
FDA Label Image

Figure-02 (Atorvastatin Figure 02)

Figure-02 (Atorvastatin Figure 02)
A line graph depicting cumulative hazard percentages over time for placebo and Atorvastatin treatments during a four-year follow-up period. The x-axis shows time in years, and the y-axis shows cumulative hazard percentage. The graph compares the hazard rates for placebo (dashed line) and Atorvastatin (solid line), with a hazard ratio (HR) of 0.63 and p-value of 0.001, indicating lower cumulative hazard for Atorvastatin.*
FDA Label Image

Figure-03 (Atorvastatin Figure 03)

Figure-03 (Atorvastatin Figure 03)
A line graph comparing the percentage of subjects experiencing an event over time between Atorvastatin 10 mg and 80 mg dosages. The x-axis shows time in years up to 5 years to first major cardiovascular endpoint. The y-axis shows the percentage of subjects experiencing the event. Two lines represent the dosages, with Atorvastatin 10 mg as a dashed line and 80 mg as a solid line. A hazard ratio (HR) of 0.78 with confidence interval (0.69-0.89) and p-value of 0.0002 is indicated.*
FDA Label Image

71205-335-30 (Image 01)

71205-335-30 (Image 01)
Atorvastatin Calcium 80 mg tablet label by Proficient Rx LP. The label states an 80 mg strength, with each tablet containing 80 mg atorvastatin calcium anhydrous. Tablets are white, oval, biconvex, film-coated, imprinted with 'MA' on one side and '4' on the other. Pack contains 30 tablets. Manufacturer: MSN Laboratories Private Limited, India. Storage instructions and barcode included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.